Floatz logo

2-(1-HEXYLOXYETHYL)-2-DEVINYLPYROPHEOPHORBIDE-A

Stage II Pancreatic Cancer AJCC v8

Mayo ClinicSmall moleculePhase 2Active
B
59/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
44/ 100
Competitive Position
89/ 100

Competitive context

36 Active assets in the Stage II Pancreatic Cancer AJCC v8 cohort.

Asset / SponsorPhaseRating
Olaparib
MOMA Therapeutics
Phase 2BB
Palbociclib
National Cancer Institute (NCI)
Phase 2BB
Gdc-0449
OHSU Knight Cancer Institute
Phase 2BB
Trastuzumab Emtansine
OHSU Knight Cancer Institute
Phase 2B
Cobimetinib
N.N. Petrov National Medical Research Center of Oncology
Phase 2B

View all 50 →

Same molecule, other indications

2-(1-HEXYLOXYETHYL)-2-DEVINYLPYROPHEOPHORBIDE-A is also rated in:

Liver NeoplasmsDormant
B
Indicative ·
62 / 100
View asset →
Liver MetastasisDormant
B
Indicative ·
57 / 100
View asset →
Advanced Pancreatic CarcinomaDormant
CCC
Indicative ·
55 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →